MTOR and breast carcinoma: We also found that the repression of TSC1 by highly expressed CXXC5 leads to abnormal activation of the mTOR signaling pathway, thereby promoting cell proliferation in vitro and accelerating the growth of breast cancer in vivo, and is involved in the process of immune escape by regulating the expression of PD-L1.